Skip to main content
    U

    U.S. Physical Therapy, Inc. (USPH)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NYSE

    $97.39
    -2.16 (-2.17%)

    Market Cap: $1.49B

    Last updated: Nov 17, 2026 at 4:10 PM ET

    U.S. Physical Therapy, Inc. (USPH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    U.S. Physical Therapy (USPH) has a market cap of $1.49B and an enterprise value of $1.69B. Its trailing P/E is 36.3x.

    Total Valuation

    Enterprise value is 13.99% above the market cap, as debt exceeds cash.

    Market Cap$1.49B
    Enterprise Value$1.69B
    Latest price (Nov 17, 2026)$97.39

    Key Dates

    The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026. The last ex-dividend date was Nov 16, 2026.

    Next Earnings DateFeb 23, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Last Ex-Dividend DateNov 16, 2026
    Next Payment DateDec 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 0.94% in the quarter ended Sep 30, 2026 and shrank 0.50% a year over 2 years.

    Shares Outstanding14.93M
    Shares Change (YoY)-1.82%
    Shares Change (QoQ)-0.94%
    Share Count Growth (2Y CAGR)-0.50%

    Valuation Ratios

    Sales and book value multiples are 1.7x and 3.4x. Its year-end P/E ranged from 29.8x to 50.3x from 2016 to 2025.

    P/E Ratio36.3x
    Forward P/E33.3x
    P/S Ratio1.7x
    Forward P/S1.7x
    P/B Ratio3.4x
    P/FCF Ratio21.0x
    P/OCF Ratio16.7x
    PEG Ratio3.0

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 16.6x EBITDA and 24.0x free cash flow.

    EV / Earnings34.0x
    EV / Sales2.0x
    EV / EBITDA16.6x
    EV / EBIT22.1x
    EV / FCF24.0x

    Price Statistics

    The stock is up 37.58% over 52 weeks and trades 12.39% above its 50-day average.

    Beta (1Y)0.25
    52-Week Change+37.58%
    1-Month Change+16.60%
    3-Month Change+24.25%
    6-Month Change+60.19%
    5-Year Change-20.42%
    10-Year Change+50.84%
    Total Return (1Y)+40.18%
    Total Return (3Y CAGR)+6.01%
    Total Return (5Y CAGR)+1.86%
    Return vs SPY (1Y)+30.55%
    Max Drawdown (1Y)-33.05%
    Max Drawdown (3Y)-46.77%
    Sharpe Ratio (1Y)0.92
    Correlation with SPY (1Y)0.09
    50-Day Average$86.65
    200-Day Average$76.73
    52-Week Range$57.16 to $101.33
    RSI (14 Days)65.0
    Average Volume (20 Days)197.21K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.42x current liabilities, and total debt is 0.57x shareholder equity.

    Current Ratio1.42x
    Quick Ratio1.42x
    Debt / Equity0.57x
    Debt / EBITDA2.47x
    Debt / FCF3.56x
    Interest Coverage6.35x

    Returns and Efficiency

    Return on invested capital is 8.54% over the last 12 months, against a 5-year average of 9.51%.

    Return on Equity (ROE)11.60%
    Return on Assets (ROA)3.84%
    Return on Invested Capital (ROIC)8.54%
    Return on Capital Employed (ROCE)6.45%
    ROE (5Y Average)12.53%
    ROA (5Y Average)5.05%
    ROIC (5Y Average)9.51%
    Asset Turnover0.67x
    Receivables Turnover8.57x

    Taxes

    Income tax took 24.67% of pretax income over the last 12 months.

    Income Tax (TTM)$16.32M
    Effective Tax Rate24.67%

    Scores

    USPH has an Altman Z-Score of 2.81, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score2.81
    Altman Z ZoneGrey
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $837.63M over the last 12 months is up 10.40% from the 12 months before.

    Revenue$837.63M
    Revenue Growth (YoY)+10.40%
    Gross Profit$334.32M
    Operating Income$76.30M
    Pretax Income$66.13M
    Net Income$49.81M
    EBITDA$99.83M
    EBIT$76.56M
    Reported EPS (TTM)$2.68

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 33.02% of the $1.30B in total assets.

    Cash and Equivalents$38.23M
    Total Debt$246.10M
    Net Debt$207.88M
    Net Debt Per Share$13.93
    Working Capital$45.54M
    Shareholder Equity$429.30M
    Book Value Per Share$28.76
    Tangible Book Value-$483.87M
    Total Assets$1.30B
    Total Liabilities$508.36M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $19.74M of capital spending, operating cash flow left $69.10M of free cash flow.

    Operating Cash Flow$88.83M
    Capital Expenditures$19.74M
    Free Cash Flow$69.10M
    FCF Per Share$4.63
    Depreciation and Amortization$23.27M
    Dividends Paid$49.00M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 9.11%, against a 5-year average of 10.67%.

    Gross Margin39.91%
    Operating Margin9.11%
    Pretax Margin7.90%
    Net Margin5.95%
    EBITDA Margin11.92%
    EBIT Margin9.14%
    FCF Margin8.25%
    Gross Margin (5Y Average)40.77%
    Operating Margin (5Y Average)10.67%
    Net Margin (5Y Average)7.98%

    Growth

    Revenue grew 12.19% a year over 3 years, and EPS fell 1.12% a year.

    Revenue Growth (3Y CAGR)+12.19%
    Revenue Growth (5Y CAGR)+13.05%
    EPS Growth (3Y CAGR)-1.12%
    EPS Growth (5Y CAGR)+1.85%
    FCF Growth (3Y CAGR)+6.64%
    FCF Growth (5Y CAGR)-7.96%
    Operating Income Growth (3Y CAGR)+15.13%
    Book Value Per Share Growth (2Y CAGR)-0.60%

    Revenue and profit by year

    Dividends and Yields

    USPH pays out 30.92% of earnings as dividends.

    Dividend Per Share (Annual)$1.84
    Dividend Yield1.89%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+3.15%
    Dividend Growth (5Y CAGR)+41.26%
    Payout Ratio30.92%
    FCF Payout Ratio70.92%
    Earnings Yield2.75%
    FCF Yield4.75%
    Shareholder Yield3.37%

    Full dividend history

    Stock Splits

    The last split was a 3-for-2 forward split on Jun 29, 2001.

    Last Split DateJun 29, 2001
    Split TypeForward split
    Split Ratio3:2

    Peer Position

    Against 8 similar companies, USPH has the 3rd highest P/E.

    P/E Ratio36.3x vs 22.6x median
    P/S Ratio1.7x vs 1.3x median
    ROIC8.54% vs 8.68% median
    Revenue Growth (Trailing 4 Quarters, YoY)+10.40% vs +16.84% median
    Dividend Yield1.89% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 9.23% and EPS growth at 13.35% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+9.23%
    EPS Growth Forecast (2Y CAGR)+13.35%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About USPH

    What is USPH's market cap?

    U.S. Physical Therapy has a market cap of $1.49B. Its enterprise value, which adds debt and subtracts cash, is $1.69B.

    What is USPH's P/E ratio?

    U.S. Physical Therapy has a trailing P/E ratio of 36.3x and a forward P/E of 33.3x.

    How many shares of USPH are outstanding?

    U.S. Physical Therapy has 14.93M shares outstanding. The count is down 1.82% from a year earlier.

    Does USPH pay a dividend?

    Yes. U.S. Physical Therapy pays $1.84 a share a year, a dividend yield of 1.89%.

    How much debt does USPH have?

    U.S. Physical Therapy has $246.10M of total debt and $38.23M of cash and equivalents, a net debt position of $207.88M.